Skip to content

da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics, sold MLTX on Jul 10, 2026

Data as of Oct 16

▼ SELL$1.4M68,289 shares at $20.02da Silva Jorge Santos Chief Executive OfficerMLTX MoonLake Immunotherapeutics
Watch MLTX
Traded
Jul 10, 2026
Disclosed
Jul 13, 2026
Filed
3 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics, sold MLTX on Jul 10, 2026TRADEDDISCLOSED
MLTXSimilar stocks (XLV — its sector index fund), rebased to MLTX's price on the disclosure day
MLTX since disclosure
−53.2%
after the sale
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund

Change in closing price from Jul 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLda Silva Jorge Santos Chief Executive OfficerMLTX MoonLake Immunotherapeutics$679Kdisclosed Jul 13 · filed 4 days after the trade

See every trade on MLTX →